Jayalakshmi Mariakuttikan | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Dr. Jayalakshmi Mariakuttikan | Medicine | Best Researcher Award

Dr. Jayalakshmi Mariakuttikan , Associate Professor , Madurai Kamaraj University , India.

Dr. M. Jayalakshmi, Ph.D., is a distinguished Associate Professor and Head of the Department of Immunology at the School of Biological Sciences, Madurai Kamaraj University, Tamil Nadu. Since 2005, she has dedicated her research to immunogenetics, focusing on disease susceptibility in South Indian populations. With postdoctoral training from UCSF, USA, and a prolific academic journey, she has mentored numerous scholars and spearheaded advanced research projects. She has delivered over 110 invited talks, published 40+ international papers, and contributed to impactful policy research. Her commitment to immunology and education underscores her stature as a respected academician and researcher in biomedical science.

Publication Profile

Scopus

Google Scholar

🎓 Education Background

Dr. Jayalakshmi earned her Ph.D. in Immunogenetics from Manonmaniam Sundaranar University, conducting her doctoral research at Holy Cross College, Nagercoil. She ranked first in her B.Sc. and M.Sc. (Zoology) programs from the same university, showcasing academic excellence early on. Her M.Phil. at St. Xavier’s College, Palayamkottai, also saw her secure the top rank. She further enhanced her expertise through a prestigious Raman Postdoctoral Fellowship at the University of California, San Francisco (UCSF), focusing on transplantation immunogenetics. Her strong academic foundation and exposure to global research platforms empower her ongoing scientific contributions in immunogenetics and molecular diagnostics.

🧪 Professional Experience

Dr. M. Jayalakshmi began her career as an Assistant Professor in 2005 at Madurai Kamaraj University and has served as Associate Professor and Head since 2017. Her academic leadership includes coordinating molecular diagnostic training, spearheading RUSA-funded research facilities, and serving as a syndicate member at MKU. She has also mentored numerous M.Sc. and Ph.D. students. With experience spanning teaching, research, and administration, she has organized skill development programs benefiting over 1,100 students. Additionally, she plays key roles in academic boards, ethics committees, and national curriculum development, consistently contributing to life science education and translational biomedical research.

🏅 Awards and Honors

Dr. Jayalakshmi’s academic brilliance has earned her multiple prestigious awards. She was a gold medalist and university topper in both B.Sc. and M.Sc. Zoology programs. She received the National Merit Scholarship and CSIR Fellowships during her Ph.D. journey. Her innovative teaching earned her the Gold Medal from Madurai Kamaraj University. She was awarded the UGC-Raman Postdoctoral Fellowship for her research at UCSF, USA, and has served as a DST-INSPIRE Mentor since 2008. Her scholarly contributions include 16 best paper awards at international conferences, reflecting her impactful presence in global immunogenetics research and scientific communication.

🔬 Research Focus

Dr. Jayalakshmi’s research centers on the immunogenetics of breast cancer, autoimmune disorders (Type 1 Diabetes, RHD), infectious diseases (HIV, HBV), and chronic kidney disease. Since 2005, she has analyzed the South Indian population’s genetic profiles using advanced tools like PCR and Next-Generation Sequencing. Her studies aim to identify genetic susceptibility markers and early diagnostic tools, contributing significantly to personalized medicine. Her lab has also explored microbiomes and HLA allele associations through funded research projects. With over 120 gene sequences and 14 whole-genome submissions to NCBI, her team’s research outcomes have international implications in immunogenomics and translational diagnostics.

🧭 Conclusion

Dr. M. Jayalakshmi exemplifies excellence in education, research, and scientific leadership in immunogenetics. Her pioneering work across cancer, infectious diseases, and autoimmune disorders in South India has advanced diagnostic research and molecular epidemiology. With a global research footprint, numerous scholarly contributions, and unwavering dedication to mentorship and innovation, she continues to inspire students and scientists alike. Through her active role in academic councils and ethical boards, she advocates for responsible science and societal health impact. Her career is a testament to the transformative power of science driven by curiosity, precision, and community engagement.

📚 Top Publication Notes

  1. Impact of unique host genetic variants in the HIV life cycle
    Human Gene (2025) — Differentiates HIV progression among South Indian females.
    Cited by: 5 articles

  2. Genomic Diversity and Antimicrobial Resistance of Acinetobacter sp.
    Indian Journal of Microbiology (2024) — Explores pan-genome and resistance markers.
    Cited by: 2 articles

  3. Association of Vitamin D receptor polymorphisms with Type 1 diabetes
    Journal of Clinical Research in Pediatric Endocrinology (2024) — Highlights VDR polymorphism link to T1D.
    Cited by: 3 articles

  4. The microbiome and rheumatic heart disease
    Acta Cardiologica (2023) — Discusses microbial links to RHD pathogenesis.
    Cited by: 1 article

  5. KIR-HLA ligand association with Type 1 Diabetes
    Immunological Investigations (2023) — Investigates KIR gene role in autoimmune risk.
    Cited by: 4 articles

  6. HLA-DRB1 Alleles with Rheumatic Heart Disease
    Immunological Investigations (2022) — Meta-analysis connecting HLA variants and RHD.
    Cited by: 6 articles

  7. HLA-G 3’UTR polymorphism and breast cancer
    Journal of Clinical Pathology (2020) — Links HLA-G variant with breast cancer susceptibility.
    Cited by: 12 articles

 

Panagiotis Dalamarinis | Medicine | Young Researcher Award

Published on by Computer Scientists Awards

Mr. Panagiotis Dalamarinis | Medicine | Young Researcher Award

Mr. Panagiotis Dalamarinis , Pediatric Physiotherapist , National and Kapodistrian University of Athens , Greece.

Panagiotis Dalamarinis is a passionate Pediatric Physiotherapist from Athens, Greece, with specialized expertise in pediatric respiratory therapy and critical care rehabilitation. He is currently pursuing a Master of Science degree in Pediatric Respiratory Medicine at the National and Kapodistrian University of Athens. With a growing academic and clinical portfolio, he combines hands-on experience in pediatric therapy with research-driven approaches in intensive care and rehabilitation. A certified trainer and an active contributor in educational and scientific forums, Panagiotis is committed to advancing child-centered therapeutic interventions through continuous learning, research, and public engagement.

Publication Profile

ORCID

🎓 Education Background

Panagiotis holds a B.Sc. in Physiotherapy from the University of Thessaly, where he completed a thesis on the impact of mHealth applications on physical activity in youth. He is now advancing his academic training with an MSc in Pediatric Respiratory Medicine at the University of Athens. Alongside, he has completed certified training in Child Psychology from Panteion University and holds top-tier language certifications including CEFR C2 in English and DELF B2 in French. His academic journey reflects a strong foundation in clinical science, complemented by multidisciplinary insights into child health and behavior.

💼 Professional Experience

Panagiotis currently works as a Pediatric Physiotherapist at Play and Therapy in Kifisia, Athens, and as a certified Trainer at the University of Thessaly’s Training and Lifelong Learning Center. His prior clinical experience includes physiotherapy roles at Nous & Ergo and a pediatric internship at the Children’s Hospital Zagreb through the Erasmus+ Program. He has also contributed as an External Expert to the Hellenic Authority for Higher Education, evaluating university programs. Panagiotis’ career demonstrates a versatile blend of clinical, academic, and regulatory contributions in pediatric and respiratory physiotherapy.

🏅 Awards and Honors

Panagiotis has received notable recognition, including the Best Undergraduate Thesis Award from the 1st Scientific Congress of Physiotherapy Students of Greece for his work on exercise capacity testing. His leadership as the Head of Advertising and Marketing during the same conference reflects his organizational strengths. His early achievements in physiotherapy highlight both academic excellence and professional involvement. These honors underscore his dedication to advancing physiotherapy science, particularly in pediatric and cardiorespiratory fields, while actively contributing to academic and student-led initiatives.

🔬 Research Focus

Panagiotis focuses on pediatric respiratory rehabilitation, mHealth integration, and critical care physiotherapy. His research includes evaluating mobile health applications for children with chronic pulmonary diseases and assessing physical activity interventions in youth populations. He has presented multiple research papers at national conferences and published peer-reviewed articles addressing respiratory therapy and exercise physiology. His interests align with evidence-based physiotherapy for vulnerable pediatric populations, leveraging both technological and therapeutic innovations to optimize rehabilitation outcomes and promote self-management in young patients.

✅ Conclusion

In summary, Panagiotis Dalamarinis exemplifies a dynamic young healthcare professional dedicated to the advancement of pediatric physiotherapy. Through clinical excellence, academic distinction, and evidence-based practice, he continues to shape the future of child-focused rehabilitation. His active involvement in education, volunteering, and scientific research reflects a comprehensive approach to healthcare service, policy, and innovation. As he progresses in his postgraduate studies and research contributions, Panagiotis stands as a promising figure in pediatric respiratory and rehabilitative sciences.

📚 Publication Top Notes

  1. Mobile health applications designed for self-management of chronic pulmonary diseases in children and adolescents: a systematic mapping review
    Year: 2023
    Journal: Jornal Brasileiro de Pneumologia (J Bras Pneumol. 2023;49(5):e20230201)
    Cited by: 12 articles

  2. Chester step test has maximum physiological exercise responses in young men and women. Comparisons with the incremental shuttle walk test
    Year: 2023
    Journal: Fysikotherapia, Volume 26, Issue 2
    Cited by: 4 articles

 

Assist. Prof. Dr. Sachin Pawar | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Sachin Pawar | Medicine | Best Researcher Award

Assistant Professor,Pharmaceutical Quality Assurance Manipal College of Pharmaceutical Sciences Manipal Academy of Higher Education, India

Dr. Sachin Dattram Pawar is an accomplished pharmaceutical scientist and Assistant Professor at the Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, MAHE, India. With a Ph.D. in Pharmaceutical Sciences and extensive expertise in analytical chemistry, formulation development, and plant metabolomics, he has contributed significantly to advanced pharmaceutical research. His international exposure includes a postdoctoral fellowship at Sorbonne University, France, and prior industrial experience as a mass spectrometry specialist. He is recognized for innovative work in LC-MS/MS, GC-MS, and MALDI-TOF analysis, contributing to impactful publications and patent filings, showcasing a deep commitment to scientific advancement.

Publication Profile

Google Scholar

ORCID

Scopus

🎓 Education Background

Dr. Pawar holds a Ph.D. in Pharmaceutical Sciences (2024) from the National Institute of Pharmaceutical Education and Research, Guwahati (NIPER-G), where he investigated the pharmacokinetics of antidepressants in combination with herbal compounds. He earned his M.Pharm in Quality Assurance (2017–2019) with distinction from Swami Ramanand Teerth Marathwada University, Nanded, and completed his B.Pharm from the same university in 2017. His academic journey reflects consistent excellence in pharmaceutical education and research training.

🧪 Professional Experience

Dr. Pawar has over four years of combined academic and industrial experience. He is currently serving as an Assistant Professor at Manipal College of Pharmaceutical Sciences. He worked as a Postdoctoral Research Fellow at Sorbonne University, France (2024), and served as a mass spectrometry specialist at Waters India Pvt. Ltd. (2023–2024). His earlier roles include Executive QA at Daewoong Pharmaceuticals and Ph.D. research fellowship at NIPER-G. Throughout his career, he has engaged in interdisciplinary work involving formulation, pharmacokinetics, plant metabolomics, and analytical development.

🏅 Awards and Honors

Dr. Pawar is a recipient of certificates of appreciation from the National Dope Testing Laboratory, New Delhi, and NIPER-G for his contributions to anti-doping research. He qualified the national-level GPAT (2019) with AIR 1549 and secured a Ph.D. fellowship through NIPER-JEE (2020). He also held a leadership role as General Secretary at Nanded Pharmacy College during his undergraduate years, reflecting his dedication to both academic excellence and student leadership.

🔬 Research Focus

Dr. Pawar’s research centers on analytical and bioanalytical method development using hyphenated techniques like LC-MS/MS, GC-MS, and MALDI-TOF. His focus areas include drug metabolism and pharmacokinetics, solid lipid nanoparticles for drug delivery, endocrine-disrupting chemical analysis, and plant metabolomics using HRMS. He has published extensively on novel formulations, bioavailability enhancement, anti-doping reference standards, and natural compound profiling, with a multidisciplinary approach bridging pharmaceutical chemistry and modern analytical tools.

🧾 Conclusion

With a rapidly growing academic and research profile, Dr. Sachin D. Pawar represents a new generation of pharmaceutical scientists contributing to quality assurance, advanced drug delivery systems, and innovative analytical methodologies. His global exposure, cutting-edge expertise, and dedication to both education and research make him a strong contender for the Best Researcher Award.

📚 Top Publication Notes

  1. Amoxapine-Loaded Solid Lipid Nanoparticles with Superior Preclinical Pharmacokinetics for Better Brain Delivery (2023) – ACS Chemical Neuroscience
    ➤ Cited by: 18 | Co-authors: Kulhari H., Kumar P., Gawali K., Murty US
    ➤ Highlight: Demonstrated enhanced brain targeting and delivery using SLNs with robust LC-MS/MS data.

  2. Synthesis and Characterization of Octopamine Sulfate, Norfenefrine Sulfate, and Etilefrine Sulfate Reference Materials (2023) – Journal of Chemical Technology & Biotechnology
    ➤ Cited by: 10 | Co-authors: Kalita SJ, Vernekar P, Sethi KK, Sahu PL, Murty US
    ➤ Highlight: Developed vital anti-doping standards using advanced analytical techniques.

  3. Physicochemical Characterization and Pharmacokinetic Assessment of Bergamottin Solid Lipid Nanoparticles (2024) – Journal of Drug Delivery Science and Technology
    ➤ Cited by: 5 | Co-authors: Jat S., Singh P., Datusalia AK, Kumar P
    ➤ Highlight: Investigated enhanced bioavailability and delivery performance of herbal bioactives.

  4. Amphiphilic Dynamic Covalent Polymer Vectors of siRNA (2024) – Chemical Science
    ➤ Cited by: 3 | Co-authors: Trousselier P., Bessin Y., Bettache N., Ulrich S.
    ➤ Highlight: Showcased innovative siRNA delivery using DCP systems, reflecting interdisciplinary prowess.

  5. Process Development for the Total Synthesis of Carboxy Toremifene as a Standard for Anti-Doping (2022) – Drug Testing and Analysis
    ➤ Cited by: 11 | Co-authors: Kumar GJ, Dubey S, Murty US, Radhakrishnanand P
    ➤ Highlight: Pioneered synthesis and characterization of doping control metabolites.

 

 

Igor Samatoshenkov | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Mr. Igor Samatoshenkov | Medicine | Best Researcher Award

Vascular surgeon, Uniclinic Brandenburg, Medical school Brandenburg, Germany

Dr. Samatoshenkov Igor Valeryevich  is an accomplished cardiovascular surgeon, innovator, and medical entrepreneur, currently based in Brandenburg, Germany. With an MD and PhD in medical sciences, he has made significant strides in the fields of vascular surgery, regenerative medicine, and gene therapy. He is the founder and CEO of “Angiolife,” a Skolkovo-based biotech company pioneering gene-drug research. As a dedicated academic and clinical expert, Dr. Samatoshenkov has been actively involved in cutting-edge surgical practice, scientific research, and medical education. 🧬💉

Publication Profile

Scopus

ORCID

🎓 Education Background

Dr. Samatoshenkov earned his PhD in 2021 from Kazan Federal University 🎓. His earlier training includes a medical degree from Kazan State Medical University (2009–2015), where he also specialized as a professional medical translator (2012–2014). He pursued advanced phlebology training in endovenous laser obliteration in 2018 in Moscow. His comprehensive education has built a solid foundation for his clinical and research pursuits. 📚🩺

💼 Professional Experience

Dr. Samatoshenkov has over a decade of experience in cardiovascular surgery and medical education. Since 2017, he has been serving in the Department of Cardiosurgery No. 1 and is a graduate student in the Department of Histology, Cytology, and Embryology. From 2015 to 2017, he was an attending physician in the Department of Heart Surgery at the ICDC. He also contributed to academia as an assistant in the Department of Normal Anatomy (2016–2017) and led several student scientific circles from 2011 to 2014. In 2018, he founded “Angiolife,” advancing gene-based therapeutics. 🏥💡

🏆 Awards and Honors

Dr. Samatoshenkov’s innovations have been widely recognized. He won the 2023 National Competition of Innovative Ideas in Medicine by AMTEC Foundation 🏅 and the “Top 50 Innovative Ideas” contest in Tatarstan 🥇. He was a finalist in the 2022 MEDLEADS competition and ranked 2nd in the 2021 All-Russian Intellectual Property contest “Intellect.” He also received accolades from the Academy of Sciences of Tatarstan (2020) and Innopolis Startup Tour (3rd place). 🌟🔬

🔬 Research Focus

Dr. Samatoshenkov’s research spans cardiovascular regeneration, gene and stem cell therapy, and surgical innovation. His pioneering studies in VEGF, ANG, and GDNF gene delivery have opened promising avenues in post-ischemic tissue recovery. His experimental models and cell-mediated delivery techniques are pushing the boundaries of modern medicine. 🧪🧠

🔚 Conclusion

With an exceptional blend of clinical excellence, scientific ingenuity, and entrepreneurial vision, Dr. Igor Samatoshenkov is a leading figure in cardiovascular innovation and regenerative therapy. His mission continues to bridge advanced research with real-world patient solutions. 🌐

📘 Top Publications

  1. Modeling of acute venous lesion of the lower extremities in experiment (2016) – Clinical and Experimental Surgery
    Authors: I.V. Samatoshenkov, B.M. Mirolyubov
    Cited by: —
    Journal Link: Not publicly available online

  2. Effects of direct and indirect delivery of the VEGF gene by cord blood cells to the area of limb ischemia in rats (2017) – Morphological Statements
    Authors: I.V. Samatoshenkov, S.A. Andreev, N.V. Boychuk
    🔗 https://doi.org/10.20340/mv-mn.2017(25).4.14-17
    Cited by: 5+

  3. Comparison of the effectiveness of stimulating angiogenesis in ischemic limbs… (2019) – Creative Cardiology
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.24022/1997-3187-2019-13-3-250-262
    Cited by: 10+

  4. Stimulation of angiogenesis of rat skeletal muscle… (2020) – Morphology
    🔗 https://doi.org/10.34922/AE.2020.157.1.006
    Cited by: 15+

  5. Adenoviral vector delivery of VEGF, angiogenin, and GDNF genes promotes angiogenesis… (2020) – BioNanoScience
    Authors: I.V. Samatoshenkov et al.
    🔗 https://doi.org/10.1007/s12668-019-00688-y
    Cited by: 25+

  6. New experimental model of hind limb ischemia in pot-bellied pigs (2023) – Microvascular Research
    Authors: Igor Samatoshenkov et al.
    🔗 https://doi.org/10.1016/j.mvr.2022.104425
    Cited by: 8+

  7. Combined delivery of the VEGF, ANG, and GDNF genes stimulates angiogenesis and post-ischemic regeneration (2024) – Current Issues in Molecular Biology
    🔗 https://doi.org/10.3390/cimb46080507
    Cited by: 12+